BRIEF-GSK files regulatory submissions in U.S. and Europe for lupus drug
 

BRIEF-GSK files regulatory submissions in U.S. and Europe for lupus drug
* GSK an**unces regulatory submissions for subcutaneousformulation of Benlysta (Belimumab) for patients with systemiclupus diseasehttp://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...Rk:V_sGLiPBpWU http://feeds.feedburner.com/~ff/reut...Rk:F7zBnMyn0Lo
http://feeds.feedburner.com/~r/reute...~4/poQBL3-5o34